5. LOS FRASEMAS EN EL SUBDOMINIO DE LA ONCOLOGÍA: ADQUISICIÓN, ESTRUCTURACIÓN CONCEPTUAL Y FORMALIZACIÓN TERMINOGRÁFICA

5.1. Introducción
5.2. Adquisición de ejemplos de candidatos a frasemas terminológicos
      5.2.1. La cadena léxica HAVE-NEOPLASM
5.3. Estructuración conceptual de frasemas en el Ontology Editor de ONTOTERM^®
      5.3.1. EVENT_RELATION_OBJECT
            5.3.1.1. HAVE-NEOPLASM_LOCATION_BODY-PART
            5.3.1.2. HAVE-NEOPLASM_AFFECTS-BODY-PART_BODY-PART
            5.3.1.3. HAVE-NEOPLASM_EXPERIENCER_PATIENT
            5.3.1.4. HAVE-NEOPLASM_TREATED-WITH-THE-USE-OF_DRUG
            5.3.1.5. HAVE-NEOPLASM_METASTATIZES-TO_BODY-PART
            5.3.1.6. HAVE-NEOPLASM_ORIGIN_BODY-PART
      5.3.2. EVENT_RELATION_EVENT
            5.3.2.1. HAVE-NEOPLASM_CAUSED-BY_DISEASE-EVENT
            5.3.2.2. HAVE-NEOPLASM_DIAGNOSED-WITH_DIAGNOSTIC-TEST
            5.3.2.3. HAVE-NEOPLASM_TREATED-WITH_TREATMENT
            5.3.2.4. HAVE-NEOPLASM_THEME-OF_MEDICAL-SERVE
            5.3.2.5. HAVE-NEOPLASM_THEME-OF_PHYSICAL-EVENT
            5.3.2.6. HAVE-NEOPLASM_HAS-SYMPTOM_DISEASE-EVENT
            5.3.2.7. HAVE-NEOPLASM_HAS-RISK-FACTOR_LIVING-EVENT
            5.3.2.8. HAVE-NEOPLASM_HAS-PROGNOSTIC-FACTOR_ LIVING-EVENT
            5.3.2.9. HAVE-NEOPLASM_RESPONDS-TO_TREATMENT
      5.3.3. EVENT_ATTRIBUTE
            5.3.3.1. HAVE-NEOPLASM_TUMOR-CONDITION: benign/ borderline/malignant
            5.3.3.2. HAVE-NEOPLASM_INVASIVE-ATTRIBUTE: preinvasive /invasive/non-invasive
            5.3.3.3. HAVE-NEOPLASM_TUMOR-SITE-ATTRIBUTE: primary/ secondary/residual
            5.3.3.4. HAVE-NEOPLASM_PRIMARY-SITE-ATTRIBUTE: known/ unknown
            5.3.3.5. HAVE-NEOPLASM_PRIMARY-TUMOR-NUMBER: first/ second
            5.3.3.6. HAVE-NEOPLASM_AFFECTED-POPULATION-AGE: adult/child
            5.3.3.7. HAVE-NEOPLASM_AFFECTED-POPULATION-SEX: male/ female
            5.3.3.8. HAVE-NEOPLASM_DIAGNOSIS: name of disease
            5.3.3.9. HAVE-NEOPLASM_PROGNOSIS-ATTRIBUTE: poor/ medium / favorable
            5.3.3.10. HAVE-NEOPLASM_TREATMENT-ATTRIBUTE: treated/ untreated
            5.3.3.11. HAVE-NEOPLASM_METASTATIC-ATTRIBUTE: metastatic /non-metastatic
            5.3.3.12. HAVE-NEOPLASM_RISK-FACTORS-EVALUATION: good /bad
            5.3.3.13. HAVE-NEOPLASM_PROGNOSTIC-FACTORS-EVALUATION poor/medium/favorable
            5.3.3.14. HAVE-NEOPLASM_CLINICAL-MANIFESTATIONS: symptomatic/asymptomatic
            5.3.3.15. HAVE-NEOPLASM_TIME-SEQUENCE: synchronous /metachronous
            5.3.3.16. HAVE-NEOPLASM_GENETIC-SUSCEPTIBILITY: familial /sporadic
            5.3.3.17. HAVE-NEOPLASM_LATERALITY: unilateral/bilateral /trilateral
            5.3.3.18. HAVE-NEOPLASM_MORTALITY-RATE: %
            5.3.3.19. HAVE-NEOPLASM_MORTALITY-RATE: low/high
            5.3.3.20. HAVE-NEOPLASM_DISEASE-SURVIVAL: disease-free/overall
            5.3.3.21. HAVE-NEOPLASM_SURVIVAL-DURATION: number of years
            5.3.3.22. HAVE-NEOPLASM_SURVIVAL-RATE: %
            5.3.3.23. HAVE-NEOPLASM_SURVIVAL-RATE: low/high
            5.3.3.24. HAVE-NEOPLASM_RISK-RATE: %
            5.3.3.25. HAVE-NEOPLASM_RISK-RATE: high/low
            5.3.3.26. HAVE-NEOPLASM_FREQUENCY-RATE: %
            5.3.3.27. HAVE-NEOPLASM_FREQUENCY-RATE: high/low
            5.3.3.28. HAVE-NEOPLASM_RISK-POTENTIAL: high/intermediate /low
            5.3.3.29. HAVE-NEOPLASM_PROGRESSION-ATTRIBUTE: stable /progressive
            5.3.3.30. HAVE-NEOPLASM_PROGRESS-RATE: rapid/slow
            5.3.3.31. HAVE-NEOPLASM_RESPONSIVENESS: complete/partial/ no response
            5.3.3.32. HAVE-NEOPLASM_RESPONSE-SEQUENCE: first/second
            5.3.3.33. HAVE-NEOPLASM_RESPONSE-TIME: slow/rapid
            5.3.3.34. HAVE-NEOPLASM_RESPONSE-DURATION: transient /durable
            5.3.3.35. HAVE-NEOPLASM_RESPONSE-DURATION: number of months/years
            5.3.3.36. HAVE-NEOPLASM_RESPONSE-RATE: %
            5.3.3.37. HAVE-NEOPLASM_RESPONSE-RATE: high/low
            5.3.3.38. HAVE-NEOPLASM_CURABILITY: curable/incurable
            5.3.3.39. HAVE-NEOPLASM_CURABILITY-RATE: %
            5.3.3.40. HAVE-NEOPLASM_CURABILITY-RATE: high/medium /low
            5.3.3.41. HAVE-NEOPLASM_CANCER-STAGING
                  5.3.3.41.1. HAVE-NEOPLASM_TNM-CLASSIFICATION
                  5.3.3.41.2. HAVE-NEOPLASM_STAGE-CLASSIFICATION
                  5.3.3.41.3. HAVE-NEOPLASM_EXTENT-CLASSIFICATION
                  5.3.3.41.4. HAVE-NEOPLASM_INVASIVENESS-DEGREE
      5.3.4. OBJECT_ATTRIBUTE
            5.3.4.1. TUMOR_SIZE: > 0
            5.3.4.2. TUMOR_SIZE: small/medium/large
            5.3.4.3. TUMOR_AMOUNT: single/multiple
            5.3.4.4. TUMOR_PALPABILITY-ATTRIBUTE: palpable /non-palpable
            5.3.4.5. TUMOR_TUMOR-CONSISTENCY: solid/serous
            5.3.4.6. TUMOR_RESECTABILITY: resectable/non-resectable
            5.3.4.7. TUMOR_SECRETION: secreting/non-secreting
            5.3.4.8. TUMOR_HISTOLOGICAL-COMPOSITION: mixed /pure
            5.3.4.9. TUMOR_HISTOLOGY-EVALUATION: favorable / unfavorable
            5.3.4.10. TUMOR_TUMOR-GRADING
                  5.3.4.10.1. TUMOR_TUMOR-DEGREE-OF-DIFFERENTIATION
                  5.3.4.10.2. TUMOR_HISTOLOGIC-TUMOR-GRADE (SCALAR)
                  5.3.4.10.3. TUMOR_HISTOLOGIC-TUMOR-GRADE (LITERAL)
                  5.3.4.10.4. TUMOR_MALIGNANCY-POTENTIAL
5.4. RECAPITULACIÓN